Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laetitia C Schwab

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|February 3, 2016
Hippocampal dysfunction defines disease onset in Huntington's diseaseFaye Begeti, Laetitia C Schwab, Sarah L Mason, et al.
Current Neuropharmacology|May 23, 2014
Effects of the KIBRA Single Nucleotide Polymorphism on Synaptic Plasticity and Memory: A Review of the LiteratureLaetitia C Schwab, Vincent Luo, Chelsey L Clarke, et al.
Expert Review of Neurotherapeutics|March 17, 2015
Dopamine and Huntington's diseaseLaetitia C Schwab, Shady N Garas, Shaady N Garas, et al.
Lancet (London, England)|January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Neurology, Neurosurgery, and Psychiatry|February 3, 2016
Hippocampal dysfunction defines disease onset in Huntington's diseaseFaye Begeti, Laetitia C Schwab, Sarah L Mason, et al.
Current Neuropharmacology|May 23, 2014
Effects of the KIBRA Single Nucleotide Polymorphism on Synaptic Plasticity and Memory: A Review of the LiteratureLaetitia C Schwab, Vincent Luo, Chelsey L Clarke, et al.
Expert Review of Neurotherapeutics|March 17, 2015
Dopamine and Huntington's diseaseLaetitia C Schwab, Shady N Garas, Shaady N Garas, et al.
Lancet (London, England)|January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.
Pageof 1